Full article: Acute kidney injury in patients receiving high-dose etoposide phosphate as
conditioning prior to hematopoietic stem cell transplantation in hematologic malignancies may be …

… The combination of carmustine, etoposide, cytarabine, and … Briefly, acute kidney failure
(ARF) was defined according to … the normal value at 10 (6 to 21) days after graft infusion. Two …

… , which occurs in 10% to 70% of patients following treatment … of acute kidney injury (AKI)
in autologous stem cell transplant … had myeloma and dialysis-dependent renal failure. All of …

… has limited its use bringing our institution to replace carmustine … However, acute kidney
injury was frequent (27.9%) and was … prognostic factors for acute renal failure (ARF). In patients …

… (HDT) followed by autologous peripheral blood stem cell transplantation (ASCT) is standard
… While much is known about the management of patients with allogenic SCT at the intensive …

… consisting of BCNU (carmustine), etoposide, cytarabine, and … After G-CSF administration,
autologous stem cells were … acute kidney injury of any grade, and transient hemodialysis was …

… of acute kidney injury (AKI) is lower with autologous compared … and graft failure were recorded
at time 0, 4 mo, and 1 y after … to chronic dialysis or the need for another kidney transplant. …

… acute complications begin with the start of conditioning chemotherapy and add to potential
toxicity for patients throughout the early post-transplant … allo-HSCT) or autologous HSCT (auto-…

… of acute complications post hematopoietic stem cell transplant … ) as early markers of kidney
injury. Moreover, CNS symptoms … Hemodialysis or hemofiltration may be required for patients …

… after induction therapy and stem cell collection. The goal of this step in MM treatment is to
achieve the best possible disease control by eradicating malignant plasma cells, … Of 24 dialysis-…